The global car t-cell therapy market size is predicted to increase from USD 7.64 billion in 2025 and is anticipated to be ...

The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...

Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard ...

By Michael Le PageImmune cells that have been genetically engineered to kill cancerous cells, known as CAR T-cells, have ...

The first-of-its-kind study shows that adding a small molecule that blocks the problematic protein to existing cancer ...

Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

Study sets stage for development of synthetic biosensors with custom-built sensing and responses for basic and translational cell engineering applications.

M Miriam Merad’s fascination with macrophages began when she looked into the lungs of a cancer patient she’d just lost during ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

The new findings offer another reason to support breastfeeding among those who can and choose to do so, especially Black ...